logo

For the Inventor, By the Inventor

Gyeonggi-do, South Korea

Sang-Ho Oh

This inventor holds 7 USPTO granted patents and 4 EPO patents. Top assignee: Yuhan Corporation. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sang-Ho Oh. Retrieved from https://idiyas.com/inventor/sang-ho-oh-str2f30r

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.1

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:

goldMedal7 out of 97 
 
Yuhan Corporation
 patents

Years Active: 2020-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents
1. 12227478 - Processes for preparing (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine or a salt thereof and processes for preparing tofacitinib using the same (2025-02-18),
2. 12187714 - Process for preparing aminopyrimidine derivatives (2025-01-07),
3. 11708362 - Process for preparing aminopyrimidine derivatives (2023-07-25),
4. 11286253 - Process for preparing aminopyrimidine derivatives (2022-03-29),
5. 11198684 - Intermediates useful for the synthesis of a selective inhibitor against protein kinase and processes for preparing the same (2021-12-14),
6. 10889578 - Process for preparing aminopyrimidine derivatives (2021-01-12),
7. 10858353 - Intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the same (2020-12-08),

Title: **Innovator Spotlight: Sang-Ho Oh**

Introduction

Sang-Ho Oh is a notable inventor based in Gyeonggi-do, South Korea, with a remarkable contribution to the pharmaceutical field through his innovative processes and compounds. With a total of seven patents to his name, Oh has made significant advancements in drug development, especially in the treatment of various health conditions.

Latest Patents

Sang-Ho Oh's latest patents include processes for preparing (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine and related compounds, crucial for synthesizing tofacitinib, a medication used for rheumatoid arthritis and other autoimmune diseases. These inventions outline a detailed methodology to create high-stability intermediates, enhancing the efficiency and effectiveness of pharmacological preparations. Additionally, he has developed an improved process for creating aminopyrimidine derivatives, which exhibit selective inhibitory activity against specific protein kinases, making strides in targeted therapies.

Career Highlights

Oh is currently associated with Yuhan Corporation, a leading pharmaceutical company in South Korea, recognized for its commitment to innovation in health care solutions. His work at Yuhan Corporation highlights his role in advancing drug formulation and development, contributing to both the company’s success and the broader medical field.

Collaborations

Throughout his career, Sang-Ho Oh has collaborated with esteemed colleagues such as Ja-Heouk Khoo and Jong-Chul Lim. Their combined expertise in pharmaceutical technology and research has propelled advancements in drug discovery and development, emphasizing teamwork in achieving significant innovations.

Conclusion

Sang-Ho Oh continues to push the boundaries of pharmaceutical science through his inventive approaches. With a strong patent portfolio and significant collaborations, he is a vital contributor to the medical industry, working towards the betterment of health solutions worldwide. His focus on innovative processes exemplifies the vital role inventors play in shaping the future of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…